Timber Pharmaceuticals Performance
| TMBRDelisted Stock | USD 1.72 0.01 0.58% |
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Timber Pharmaceuticals are completely uncorrelated. Timber Pharmaceuticals right now has a risk of 0.0%. Please validate Timber Pharmaceuticals accumulation distribution and period momentum indicator , to decide if Timber Pharmaceuticals will be following its existing price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Timber Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, Timber Pharmaceuticals is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors. ...more
| Begin Period Cash Flow | 16.8 M |
Timber |
Timber Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 172.00 in Timber Pharmaceuticals on October 26, 2024 and sell it today you would earn a total of 0.00 from holding Timber Pharmaceuticals or generate 0.0% return on investment over 90 days. Timber Pharmaceuticals is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Timber, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Timber Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Timber Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Timber Pharmaceuticals, and traders can use it to determine the average amount a Timber Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| TMBR |
Based on monthly moving average Timber Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Timber Pharmaceuticals by adding Timber Pharmaceuticals to a well-diversified portfolio.
Timber Pharmaceuticals Fundamentals Growth
Timber Stock prices reflect investors' perceptions of the future prospects and financial health of Timber Pharmaceuticals, and Timber Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Timber Stock performance.
| Return On Equity | -3.43 | |||
| Return On Asset | -1.37 | |||
| Current Valuation | (916.94 K) | |||
| Shares Outstanding | 3.43 M | |||
| Price To Book | 6.94 X | |||
| Price To Sales | 17.19 X | |||
| Revenue | 83.18 K | |||
| EBITDA | (19.16 M) | |||
| Cash And Equivalents | 11.22 M | |||
| Cash Per Share | 3.78 X | |||
| Total Debt | 331.15 K | |||
| Debt To Equity | 0.06 % | |||
| Book Value Per Share | (0.86) X | |||
| Cash Flow From Operations | (15.85 M) | |||
| Earnings Per Share | (1.97) X | |||
| Total Asset | 10.28 M | |||
| Retained Earnings | (48.26 M) | |||
About Timber Pharmaceuticals Performance
Assessing Timber Pharmaceuticals' fundamental ratios provides investors with valuable insights into Timber Pharmaceuticals' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Timber Pharmaceuticals is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company was founded in 2019 and is headquartered in Basking Ridge, New Jersey. Timber Pharmaceuticals operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 5 people.Things to note about Timber Pharmaceuticals performance evaluation
Checking the ongoing alerts about Timber Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Timber Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Timber Pharmaceuticals is not yet fully synchronised with the market data | |
| Timber Pharmaceuticals may become a speculative penny stock | |
| Timber Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 83.18 K. Net Loss for the year was (19.38 M) with loss before overhead, payroll, taxes, and interest of (5.26 M). | |
| Timber Pharmaceuticals currently holds about 11.22 M in cash with (15.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.78, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Timber Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Timber Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Timber Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Timber Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Timber Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Timber Pharmaceuticals' stock. These opinions can provide insight into Timber Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in Timber Stock
If you are still planning to invest in Timber Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Timber Pharmaceuticals' history and understand the potential risks before investing.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |